| Literature DB >> 25376235 |
Lucia R Machado, Zilda M Meneghelo, David C S Le Bihan, Rodrigo B M Barretto, Antonio C Carvalho, Valdir A Moises1.
Abstract
BACKGROUND: Left atrium enlargement has been associated with cardiac events in patients with mitral regurgitation (MR). Left atrium reverse remodeling (LARR) occur after surgical correction of MR, but the preoperative predictors of this phenomenon are not well known. It is therefore important to identify preoperative predictors for postoperative LARR.Entities:
Mesh:
Year: 2014 PMID: 25376235 PMCID: PMC4232670 DOI: 10.1186/1476-7120-12-45
Source DB: PubMed Journal: Cardiovasc Ultrasound ISSN: 1476-7120 Impact factor: 2.062
Baseline patient characteristics
| Variables | n (%) |
|---|---|
| Male sex | 37 (59.7) |
| Body surface area (m2); mean ± SD | 1.73 ± 0.19 |
| Stage 1 systemic hypertension | 37 (59.7) |
| Rhythm: | |
| Sinus | 50 (80.6) |
| Atrial fibrillation | 12 (19.4) |
| Functional class: | |
| II | 43 (69.4) |
| III / IV | 19 (30,6) |
| Medications: | |
| Diuretic | 54 (84.4) |
| ACE inhibitor | 38 (59.4) |
| Beta blocker | 25 (39.1) |
| Calcium channel blocker | 9 (14.1) |
| Digoxin | 9 (14.1) |
| Amiodarone | 1 (1.6) |
| Aspirin | 13 (20.3) |
| Oral anticoagulant | 3 (4.7) |
ACE: angiotensin converter enzyme; SD: standard deviation.
Echocardiographic variables
| Variables | Before surgery | After surgery |
|
|---|---|---|---|
| LAVI (mL/m2) | 85.5 ± 36.8 | 49.7 ± 25.1 | < 0.001 |
| LVdD (mm) | 61.0 ± 5.3 | 52.4 ± 5.5 | < 0.001 |
| LVsD (mm) | 38.3 ± 5.2 | 35.3 ± 6.0 | < 0.001 |
| LVdV (mL) | 133.8 ± 40.1 | 98.2 ± 32.1 | < 0.001 |
| LVsV (mL) | 46.5 ± 23.3 | 41.6 ± 19.8 | 0.23 |
| LVEF (%) | 66.1 ± 7.5 | 59.1 ± 9.1 | < 0.001 |
Values given as mean ± standard deviation.
LAVI: left atrium volume index; LVdD: left ventricle diastolic diameter; LVsD: left ventricle systolic diameter; LVdV: left ventricle diastolic volume; LVsV: left ventricle systolic volume; LVEF: left ventricle ejection fraction.
Comparison of age and preoperative echocardiographic variables of patients with or without postoperative left atrium reverse remodeling
| Variable | LAVI reduction <25% (n = 16) | LAVI reduction ≥25% (n = 46) |
|
|---|---|---|---|
| Age (years) | 50.3 ± 17.3 | 53.3 ± 14.3 | 0.42 |
| LAVI (mL/m2) | 77.3 ± 39 | 88.4 ± 36 | 0.15 |
| LVdD (mm) | 61,6 ± 5.4 | 60.8 ± 5.3 | 0.75 |
| LVsD (mm) | 39.8 ± 5.0 | 37.8 ± 5.1 | 0.25 |
| LVdV (mL) | 151 ± 46 | 128 ± 37 | 0.050 |
| LVsV (mL) | 60 ± 28 | 42 ± 20 | 0.022 |
| LVEF (%) | 63 ± 9.0 | 67 ± 6.7 | 0.034 |
| RV (mL) | 88 ± 27 | 96 ± 45 | 0.88 |
| EROA (cm2) | 0.56 ± 0.18 | 0.60 ± 0.24 | 0.83 |
Values given as mean ± standard deviation.
EROA: effective regurgitant orifice area; LAVI: left atrium volume index; LVdD: left ventricle diastolic diameter; LVsD: left ventricle systolic diameter; LVdV: left ventricle diastolic volume; LVsV: left ventricle systolic volume; LVEF: left ventricle ejection fraction; RV: mitral valve regurgitant volume per beat.